Universal Health Services (UHS) FY2018 results: revenue $10.8 billion, up 3.5% on the year
Universal Health Services Inc. (UHS) reported revenue of $10.8 billion for fiscal 2018, the year ended 31 December 2018, up 3.5% on the year before. Net income was $780 million, up 3.6%, and diluted earnings per share $8.31. The figures are the company's own, from the 10-K it filed with the SEC on 27 February 2019.
Revenue
$10.8 billion
+3.5% on the year
FY2011FY2018
Operating margin
10.9%
12.3% a year earlier
FY2011FY2018
Net income
$780 million
+3.6% on the year
FY2011FY2018
Diluted EPS
$8.31
+6.4% on the year
FY2011FY2018
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2018
FY2017
FY2016
On the year
Last 8 years
Revenue
10,772
10,410
9,766
+3.5%
Operating income
1,175
1,280
1,281
-8.2%
Operating margin
10.9%
12.3%
13.1%
Interest expense
155
145
125
+6.7%
Pre-tax income
1,035
1,135
1,156
-8.9%
Income tax
237
364
409
-34.9%
Effective tax rate
22.9%
32.0%
35.4%
Net income
780
752
702
+3.6%
Net margin
7.2%
7.2%
7.2%
Diluted EPS
$8.31
$7.81
$7.14
+6.4%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2018
FY2017
FY2016
On the year
Last 8 years
Operating cash flow
1,275
1,248
1,334
+2.2%
Capital expenditure
665
558
520
+19.3%
Free cash flow
610
690
814
-11.6%
Free cash flow margin
5.7%
6.6%
8.3%
Cash from investing
-747
-685
-1,155
Cash from financing
-492
-519
-171
Depreciation and amortisation
453
448
417
+1.2%
Share-based compensation
66.6
56.7
48.1
+17.3%
Buybacks
397
364
353
+9.1%
Dividends paid
37.3
38.2
38.9
-2.3%
Dividend per share
$0.40
n/a
n/a
Diluted shares, weighted
94m
96m
98m
-2.7%
Balance sheet
$ million
FY2018
FY2017
FY2016
On the year
Last 8 years
Shareholders' equity
5,389
4,990
4,533
+8.0%
Non-controlling interest
76.5
61.9
64.4
+23.6%
Redeemable equity
4.3
6.7
9.3
-36.0%
Debt
3,999
4,040
4,136
-1.0%
Operating lease liabilities
0.0
n/a
n/a
Other liabilities
1,797
1,664
1,575
+8.0%
Total liabilities and equity
11,265
10,762
10,318
+4.7%
Fixed assets
4,848
4,572
4,331
+6.0%
Goodwill
3,845
3,825
3,784
+0.5%
Intangible assets
173
220
228
-21.4%
Cash and equivalents
105
74.4
33.7
+41.4%
Receivables
1,510
1,501
1,440
+0.6%
Other assets
785
570
501
+37.8%
Total assets
11,265
10,762
10,318
+4.7%
10-K for the year ended 31 December 2018, filed 27 February 2019: the filing.